We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Takes First Step Toward Revoking ANDA
Kite Pharma Wins Breakthrough Therapy Designation From FDA for KTE-C19
Merck KGaA, Threshold Cancer Drug Falls Short in Phase 3
Xbiotech’s Xilonix Meets Primary Endpoints for Advanced Colorectal Cancer